Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 43, 2017 - Issue 1: Oral administration
Submit an article Journal homepage
736
Views
27
CrossRef citations to date
0
Altmetric
Research Articles

Co-delivery of pemetrexed and miR-21 antisense oligonucleotide by lipid-polymer hybrid nanoparticles and effects on glioblastoma cells

Berrin KüçüktürkmenDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, Ankara, Turkey;
,
Burcu DevrimDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, Ankara, Turkey;
,
Ongun M. SakaDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, Ankara, Turkey;
,
Şükran YilmazFoot and Mouth Disease Institute, Ankara, Turkey
,
Taibe ArsoyFoot and Mouth Disease Institute, Ankara, Turkey
&
Asuman BozkirDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, Ankara, Turkey; Correspondence[email protected]
Pages 12-21 | Received 29 Jan 2016, Accepted 05 Jun 2016, Published online: 29 Jun 2016

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Nayab Tahir, Asadullah Madni, Alexandra Correia, Mubashar Rehman, Vimalkumar Balasubramanian, Muhammad Muzamil Khan & Hélder A Santos. (2019) Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy. International Journal of Nanomedicine 14, pages 4961-4974.
Read now

Articles from other publishers (26)

Rajeswara Babu MythriM.R. Aishwarya. (2023) BIOPOLYMERS AS PROMISING VEHICLES FOR DRUG DELIVERY TO THE BRAIN. Drug Metabolism Reviews, pages 1-40.
Crossref
Ming Chen, Bryan Kim, Neil Robertson, Sujan Kumar Mondal, Zdravka Medarova & Anna Moore. (2023) Co-administration of temozolomide (TMZ) and the experimental therapeutic targeting miR-10b, profoundly affects the tumorigenic phenotype of human glioblastoma cells. Frontiers in Molecular Biosciences 10.
Crossref
Man Amanat, Christina L. Nemeth, Amena Smith Fine, Doris G. Leung & Ali Fatemi. (2022) Antisense Oligonucleotide Therapy for the Nervous System: From Bench to Bedside with Emphasis on Pediatric Neurology. Pharmaceutics 14:11, pages 2389.
Crossref
José Marcos Jiménez-Morales, Yanet Elisa Hernández-Cuenca, Ander Reyes-Abrahantes, Henry Ruiz-García, Francisco Barajas-Olmos, Humberto García-Ortiz, Lorena Orozco, Alfredo Quiñones-Hinojosa, Jesús Reyes-González & María del Carmen Abrahantes-Pérez. (2022) MicroRNA delivery systems in glioma therapy and perspectives: A systematic review. Journal of Controlled Release 349, pages 712-730.
Crossref
Tanwi Vartak, Soundharya Kumaresan & Eoin Brennan. (2022) Decoding microRNA drivers in atherosclerosis. Bioscience Reports 42:7.
Crossref
Saurabh Shah, Paras Famta, Rajeev Singh Raghuvanshi, Shashi Bala Singh & Saurabh Srivastava. (2022) Lipid polymer hybrid nanocarriers: Insights into synthesis aspects, characterization, release mechanisms, surface functionalization and potential implications. Colloid and Interface Science Communications 46, pages 100570.
Crossref
Siddhi Lokhande, Ujwala A. Shinde, Agnivesh Shrivastava & Kavita H. Singh. 2022. Nanocarriers for Drug-Targeting Brain Tumors. Nanocarriers for Drug-Targeting Brain Tumors 587 622 .
Manasa Manjunath Hegde, Suma Prabhu, Srinivas Mutalik, Abhishek Chatterjee, Jayant S. Goda & B. S. Satish Rao. (2021) Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches. Journal of Pharmaceutical Investigation 52:1, pages 49-74.
Crossref
Ayça EREK, Safiye Kübra AKTAŞ, Yağmur ÖZDEMİR & Güliz AK. (2021) Alginate/Chitosan Nanoparticles for Adsorption and Controlled Release of PemetrexedAljinat/Kitosan Nanopartiküllere Pemetrekset Adsorpsiyonu ve Kontrollü İlaç Salımı. Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi 14:3, pages 1066-1076.
Crossref
Yuanyuan Liu, Meng Zheng, Mingzhu Jiao, Chengnan Yan, Sen Xu, Qiuli Du, Marco Morsch, Jinlong Yin & Bingyang Shi. (2021) Polymeric nanoparticle mediated inhibition of miR-21 with enhanced miR-124 expression for combinatorial glioblastoma therapy. Biomaterials 276, pages 121036.
Crossref
Ming Chen, Zdravka Medarova & Anna Moore. (2021) Role of microRNAs in glioblastoma. Oncotarget 12:17, pages 1707-1723.
Crossref
Rebecca Raue, Ann-Christin Frank, Shahzad Nawaz Syed & Bernhard Brüne. (2021) Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment. International Journal of Molecular Sciences 22:4, pages 2210.
Crossref
Faheem Hyder Pottoo, Md. Noushad Javed, Jawad Ur Rahman, Tareq Abu-Izneid & Firdos Alam Khan. (2021) Targeted delivery of miRNA based therapeuticals in the clinical management of Glioblastoma Multiforme. Seminars in Cancer Biology 69, pages 391-398.
Crossref
Jasjeet Kaur Narang, Anmol Dogra, Javed Ali, Sanjula Baboota & R.S. Narang. 2021. Nanocarriers for the Delivery of Combination Drugs. Nanocarriers for the Delivery of Combination Drugs 85 118 .
Gizem Rüya Topal, Mária Mészáros, Gergő Porkoláb, Anikó Szecskó, Tamás Ferenc Polgár, László Siklós, Mária A. Deli, Szilvia Veszelka & Asuman Bozkir. (2020) ApoE-Targeting Increases the Transfer of Solid Lipid Nanoparticles with Donepezil Cargo across a Culture Model of the Blood–Brain Barrier. Pharmaceutics 13:1, pages 38.
Crossref
Justin G. Rosch, Allison N. DuRoss, Madeleine R. Landry & Conroy Sun. (2020) Development of a Pemetrexed/Folic Acid Nanoformulation: Synthesis, Characterization, and Efficacy in a Murine Colorectal Cancer Model. ACS Omega 5:25, pages 15424-15432.
Crossref
Ongun Mehmet Saka, Umut Can Öz, Berrin Küçüktürkmen, Burcu Devrim & Asuman Bozkır. (2018) Central Composite Design for Optimization of Zoledronic Acid Loaded PLGA Nanoparticles. Journal of Pharmaceutical Innovation 15:1, pages 3-14.
Crossref
Shahryar Shakeri, Milad Ashrafizadeh, Ali Zarrabi, Rasoul Roghanian, Elham Ghasemipour Afshar, Abbas Pardakhty, Reza Mohammadinejad, Anuj Kumar & Vijay Kumar Thakur. (2020) Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics. Biomedicines 8:1, pages 13.
Crossref
Dina G. Zayed, Shaker M. Ebrahim, Maged W. Helmy, Sherine N. Khattab, Mohammed Bahey-El-Din, Jia-You Fang, Kadria A. Elkhodairy & Ahmed O. Elzoghby. (2019) Combining hydrophilic chemotherapy and hydrophobic phytotherapy via tumor-targeted albumin–QDs nano-hybrids: covalent coupling and phospholipid complexation approaches. Journal of Nanobiotechnology 17:1.
Crossref
Bibhash C. Mohanta, Narahari N. Palei, Vijayaraj Surendran, Subas C. Dinda, Jayaraman Rajangam, Jyotirmoy Deb & Biswa M. Sahoo. (2019) Lipid Based Nanoparticles: Current Strategies for Brain Tumor Targeting. Current Nanomaterials 4:2, pages 84-100.
Crossref
Ali Gharieh, Sepideh Khoee & Ali Reza Mahdavian. (2019) Emulsion and miniemulsion techniques in preparation of polymer nanoparticles with versatile characteristics. Advances in Colloid and Interface Science 269, pages 152-186.
Crossref
Shruti Rawal & Mayur M. Patel. (2019) Threatening cancer with nanoparticle aided combination oncotherapy. Journal of Controlled Release 301, pages 76-109.
Crossref
Berrin Küçüktürkmen & Asuman Bozkır. 2019. Nanoarchitectonics in Biomedicine. Nanoarchitectonics in Biomedicine 335 369 .
Indranil Mondal, Shivani Sharma & Ritu Kulshreshtha. 2019. AGO-Driven Non-Coding RNAs. AGO-Driven Non-Coding RNAs 261 292 .
Saini Setua, Meena Jaggi, Murali M. Yallapu, Subhash C. Chauhan, Anna Danilushkina, Hojae Lee, Insung S. Choi, Rawil Fakhrullin, Lorenzo Degli Esposti, Anna Tampieri, Michele Iafisco, Maxim Shevtsov & Gabriele Multhoff. 2018. Nanotechnologies in Preventive and Regenerative Medicine. Nanotechnologies in Preventive and Regenerative Medicine 399 511 .
Narahari N. Palei, Bibhash C. Mohanta, Mohana L. Sabapathi & Malay K. Das. 2018. Organic Materials as Smart Nanocarriers for Drug Delivery. Organic Materials as Smart Nanocarriers for Drug Delivery 415 470 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.